BioClinica®, Inc.,(NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization.
Cato Research selected BioClinica’s clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.
“Our customers told us that improved CTMS functionality was a critical part of their strategy to connect information across their trials and improve overall efficiency. We believe BioClinica CTMS is the best available solution supporting those requirements.”
“After an extensive product search, we were impressed with BioClinica’s technology and the efficiencies that technology will create for both Cato Research employees and our clients,” said Dr. Allen Cato, President of Cato Research.
“One of our specialties is supporting multifaceted development programs that require innovative regulatory and clinical strategies. BioClinica’s CTMS will assist us in this by helping us streamline our workflow and facilitate the clinical study processes.”
“BioClinica is pleased to be selected by Cato Research for its clinical trial management needs after such an in-depth selection process,” said Peter Benton, President of BioClinica’s eClinical division.
“We have seen a significant increase in customer interest in our CTMS solutions because these solutions provide the scalability needed to support global research and the flexibility sponsors need to create more efficient eClinical environments.”
CTMS applications help to manage business and operational processes for clinical trials by capturing and manipulating the trial data electronically.
BioClinica’s CTMS capabilities include applications to manage data related to clinical sites, personnel, subjects, and clinical supplies; scheduling, tracking, and monitoring performance; site payments; study document management; vendors; and more.
BioClinica Office-Smart Clinical Trial Manager (Office-Smart CTMS) is supported by Microsoft SharePoint and BioClinica technologies to provide superior team collaboration, connectivity, and efficiency in a multisite environment; it is the only CTMS capable of fully utilizing the Microsoft Office environment.
With its ClinBUS Connector, BioClinica’s CTMS interfaces with a variety of systems, such as electronic data capture and interactive voice or web response systems, to allow full integration of all clinical data.
“Office-Smart CTMS is an important facet of BioClinica’s vision of a next-generation eClinical platform,” said Mark Weinstein, CEO of BioClinica. “Our customers told us that improved CTMS functionality was a critical part of their strategy to connect information across their trials and improve overall efficiency. We believe BioClinica CTMS is the best available solution supporting those requirements.”
SOURCE BioClinica, Inc.